Menglu Gao , Si Wu , Xin Hu , Lihan Zhu , Yue Hu , Xin He , Jiurong He , Rong Yuan , Yinhua Zhang , Cheng Liu , Fu-Bing Wang
{"title":"Cas13-mediated liquid biopsy: A comprehensive review of cancer diagnostic applications","authors":"Menglu Gao , Si Wu , Xin Hu , Lihan Zhu , Yue Hu , Xin He , Jiurong He , Rong Yuan , Yinhua Zhang , Cheng Liu , Fu-Bing Wang","doi":"10.1016/j.trac.2025.118411","DOIUrl":null,"url":null,"abstract":"<div><div>Over the past decade, CRISPR-based molecular editing technologies have found extensive applications across various disease domains. Among them, CRISPR Cas13, a significant member of the CRISPR family, has been employed in a non-invasive diagnostic method that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), microRNAs (miRNAs), and extracellular vehicles (EVs) isolated from biological fluids such as blood, urine, saliva, cerebrospinal fluid, and pleural effusion. This has established CRISPR Cas13 as a crucial tool in tumor liquid biopsies. We have reviewed the structural compositions of different CRISPR Cas13 members and optimization strategies for the Cas13 reaction system, including guiding RNA (gRNA) design, integration of nanomaterials, electrochemical sensors, and microfluidic chips. By examining Cas13 applications in both <em>in vivo</em> and <em>in vitro</em> tumor detection, we delve into the innovative and practical potential of these approaches and highlight their promise as transformative tools in cancer diagnostics.</div></div>","PeriodicalId":439,"journal":{"name":"Trends in Analytical Chemistry","volume":"193 ","pages":"Article 118411"},"PeriodicalIF":12.0000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Analytical Chemistry","FirstCategoryId":"1","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165993625002791","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Over the past decade, CRISPR-based molecular editing technologies have found extensive applications across various disease domains. Among them, CRISPR Cas13, a significant member of the CRISPR family, has been employed in a non-invasive diagnostic method that analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), microRNAs (miRNAs), and extracellular vehicles (EVs) isolated from biological fluids such as blood, urine, saliva, cerebrospinal fluid, and pleural effusion. This has established CRISPR Cas13 as a crucial tool in tumor liquid biopsies. We have reviewed the structural compositions of different CRISPR Cas13 members and optimization strategies for the Cas13 reaction system, including guiding RNA (gRNA) design, integration of nanomaterials, electrochemical sensors, and microfluidic chips. By examining Cas13 applications in both in vivo and in vitro tumor detection, we delve into the innovative and practical potential of these approaches and highlight their promise as transformative tools in cancer diagnostics.
期刊介绍:
TrAC publishes succinct and critical overviews of recent advancements in analytical chemistry, designed to assist analytical chemists and other users of analytical techniques. These reviews offer excellent, up-to-date, and timely coverage of various topics within analytical chemistry. Encompassing areas such as analytical instrumentation, biomedical analysis, biomolecular analysis, biosensors, chemical analysis, chemometrics, clinical chemistry, drug discovery, environmental analysis and monitoring, food analysis, forensic science, laboratory automation, materials science, metabolomics, pesticide-residue analysis, pharmaceutical analysis, proteomics, surface science, and water analysis and monitoring, these critical reviews provide comprehensive insights for practitioners in the field.